Articles tagged with Neutrophils
Researchers have discovered the molecular sensor that detects wound-induced hydrogen peroxide, orchestrating the marshaling of immune cells. This finding has broad implications for cancer biology, wound healing and infection fighting.
Researchers discovered a new class of molecules inhibiting white blood cell recruitment to sites of inflammation in the body. This breakthrough offers a more targeted approach to treating diseases like Inflammatory Bowel Disease (IBD).
Alison K. Criss, a young investigator at the University of Virginia, receives the ICAAC Young Investigator Award for her outstanding research on bacterial pathogenesis. Her work focuses on the interactions between Neisseria gonorrhoeae and host cells, with implications for understanding bacterial evasion mechanisms.
Researchers find that a specific white blood cell type, neutrophils, promote tumor growth and spread by inducing new blood vessel formation. This discovery opens the door to developing novel drugs targeting early-stage cancers.
Researchers have discovered that sandfly saliva plays a critical role in Leishmaniasis, evading neutrophils and allowing parasites to survive within human hosts. This finding provides a new target for drug development and may lead to more accurate assessments of infection severity.
A study found that certain white blood cells, called neutrophils, can re-enter the bloodstream and cause damage to unconnected organs after trauma or major surgery. Researchers believe this process is controlled by a protein on the surface of blood vessels called JAM-C.
Researchers developed an effective gene therapy technique using induced pluripotent stem cells to correct chronic granulomatous disease in cell culture. The corrected neutrophils produced normal levels of hydrogen peroxide, potentially offering a cure for the rare disorder.
Researchers found that certain immune system cells can hinder wound healing, leading to chronic ulcers. Supressing these cells may speed up the healing process.
Researchers at Washington University School of Medicine discovered a gene that limits lung damage during acute stress. The bcl3 gene prevents excessive neutrophil production, which can cause life-threatening breathing problems and rapid lung failure.
Mice lacking CEACAM1 have excess neutrophils but suffer from accelerated mortality due to liver damage and severe tissue harm. These findings suggest that natural mechanisms restraining white blood cell proliferation are crucial in treating infectious and auto-inflammatory disorders.
A new study reveals that immune cells use chromatin to form defensive webs, catching and killing pathogens with the help of enzymes neutrophil elastase and myeloperoxidase. The discovery opens up a new understanding of how the body defends against infection.
A study published in Science shows that neutrophils release enzymes that cause collateral damage to surrounding tissue, leading to chronic lung diseases. However, another enzyme LTA4H degrades a molecular fragment PGP, breaking the cycle and preventing damage.
A team of scientists developed a new microfluidic tool to quickly and accurately isolate neutrophils from small blood samples, enabling researchers to study the immune system's response to traumatic injury. The device revealed complex gene expression patterns that shifted during the recovery process.
A study by LMU researchers found that neutrophils play a crucial role in blood coagulation and antimicrobial defense, trapping pathogens in small blood vessels. Excessive clotting, however, can lead to life-threatening conditions like heart attack and stroke.
Researchers have made significant discoveries in the fields of atherosclerosis and Alzheimer's disease, revealing new insights into the role of neutrophils and hyperploidy. A study found that neutrophils contribute to atherosclerosis, while another discovered that hyperploid neurons are more prone to cell death in Alzheimer's disease.
Researchers found that competition between rival bacteria can cause deadlier forms of bacteria to evolve, making them more deadly when they enter the bloodstream. This can lead to serious diseases like pneumonia and meningitis.
GSK-3 inhibitors may have adverse effects on the heart, while NMDA molecules could provide nerve cell protection, highlighting the need for careful risk-benefit assessments. These findings have implications for developing new treatments for conditions such as Alzheimer's disease and diabetes.
Researchers found that older rats take twice as long to recover their sense of taste compared to younger counterparts. A balanced response between neutrophils and macrophages enhances recovery, but the exact mechanisms are not fully understood.
Researchers discover that beneficial gut bacteria play a crucial role in priming the immune system to combat future infections. The study found that these 'good' bacteria influence neutrophils, white blood cells that help fight infection, and suggest that prolonged antibiotic use may compromise immune function.
Researchers discovered that neutrophils, a type of white blood cell, lose their direction when the protein p55 is absent. This leads to impaired healing and slower response times to infections.
Researchers at LSU Health Sciences Center have identified interleukin-17 (IL-17) as a potential therapeutic target to prevent acute lung injury from influenza infection. Blocking IL-17 signaling may reduce inflammation and lung damage, offering new hope for flu-related complications.
A study published in the Journal of Dental Research found that dental plaque accumulation led to increased neutrophil activity in black males, but not in other groups. This response may indicate a higher risk for infections and heart disease in these individuals.
Researchers discovered that premature newborns lack the ability to form a 'death NET', a crucial white blood cell trap that kills bacteria. This defect may contribute to severe infections like sepsis and pneumonia in preterm babies, highlighting the need for new treatments.
Researchers discovered that neutrophils respond to conflicting signals from cystic fibrosis patients' lungs, leading to severe lung damage. The study's findings suggest that targeting the molecular pathway responsible for this response could lead to new disease therapies.
Researchers found a correlation between small genetic differences in the IFRD1 gene and lung disease severity in cystic fibrosis patients. The study also discovered that the IFRD1 protein regulates neutrophil function, which causes inflammatory damage to airways.
Researchers identified IFRD1 as a gene that modifies cystic fibrosis lung disease severity by regulating neutrophil function. Deleting IFRD1 in mice reduced inflammation and disease, suggesting potential new targets for treatment.
A new study suggests blocking neutrophil migration using rhAPC could eliminate bleeding risk from sepsis treatment. The results recommend existing drugs as potential new treatments against sepsis, increasing the pace of new treatments in the clinic.
Researchers have identified apolipoprotein(a) as a natural regulator of inflammation, inhibiting neutrophil recruitment in vivo and reducing inflammatory responses. This novel function of apo(a) is independent of its molecular mimicry of plasminogen.
Researchers discovered that Leishmania major parasites exploit the body's wound-healing response to sand fly bites, evading death and establishing long-term infection. Neutrophils play a critical role in the development of the disease, allowing parasites to survive inside them before escaping into macrophages.
A phase I/II study found that intrabone administration of unrelated cord-blood cells increased the number of patients who could receive hematopoietic stem-cell transplantation. The technique reduced the incidence of graft-versus-host disease, a common complication of allogeneic transplants.
Researchers at UIC have identified a novel function for an enzyme involved in tissue injury in acute respiratory distress syndrome (ARDS). The finding offers new therapeutic targets for lung inflammation and injury prevention.
Researchers found a connection between an immune protein and glucose levels, offering a new avenue for treating diabetics who don't respond to traditional insulin-based treatments. The protein, defensin HNP-1, inhibits glucose-producing genes and reduces blood sugar levels in both normal mice and diabetic rats.
New research reveals that nicotine reduces neutrophil ability to seek and destroy bacteria, contributing to increased susceptibility to infection in chronic tobacco users. The study also found that nicotine suppresses oxidative burst and increases matrix metalloproteinase-9 release, leading to impaired neutrophil function.
Researchers have identified the molecular mechanics behind Severe Congenital Neutropenia (SCN), a deadly disease characterized by a deficiency of neutrophils. The discovery of GFI1's role in regulating neutrophil development has provided new avenues for understanding the molecular basis of SCN.
Researchers have designed an implantable cell retriever and reprogrammer that can isolate and manipulate specific cell populations with great efficiency. The device uses the mechanics of blood flow to capture viable stem cells, which are rare in the bloodstream.
Researchers found that platelets' GPIIb/IIIa receptors stimulate neutrophils to produce TNF, a key inflammatory compound. This discovery may lead to the development of new anti-inflammatory drugs targeting these receptors.
Researchers discovered that neutrophils recognize and respond to a specific form of sugar called beta-1,6-glucan on the surface of fungi, which elicits a stronger reaction than another sugar with similar chemical properties. This unique sugar may help stimulate the immune system and combat deadly pathogens.
Researchers at UF discovered that anthrax's lethal toxin immobilizes neutrophils by preventing actin assembly, leaving them unable to protect against infection. This finding may lead to a diagnostic blood test within hours of detection, allowing for quicker treatment and potentially saving lives.
Researchers have identified potential new treatments for three serious diseases: a drug that increases SMN production in mice with spinal muscular atrophy, overexpression of Akt that converts a less invasive to a highly invasive melanoma, and inhibition of PKC-epsilon that prevents insulin resistance in non-alcoholic fatty liver disease
In a breakthrough study, researchers found that neutrophils in the lungs produce histamine in response to infection, contradicting the long-held assumption that mast cells are the primary source. This discovery has implications for asthma and bronchitis treatments, suggesting antihistamines may be a viable therapeutic option.
Researchers discovered that neutrophils can form web-like structures called NETs outside cells, composed of nucleic acid and enzymes that catch bacteria and kill them. This process is equally effective as devouring bacteria, showcasing the neutrophil's role in defense even after death.
A team of University of Iowa researchers has made significant progress in understanding how the deadly Francisella tularensis bacterium evades the human immune system. The study found that the bacteria can inhibit the ability of white blood cells called neutrophils to kill it, allowing it to replicate and cause harm.
Researchers at UCSD have identified the internal compass that allows neutrophils to detect and migrate towards chemoattractants. This discovery could lead to novel anti-inflammatory drugs for treating chronic inflammatory diseases.
For hematopoietic stem cells, a two-step process regulates cell fate decisions, with pioneer transcription factors triggering the first step and secondary factors activating specific genes. Understanding this circuitry is crucial for learning how to transform stem cells into therapeutically useful cells.
Researchers found that GM-CSF and TNF-alpha induce the phosphorylation of a serine residue on NADPH oxidase, priming it for action at sites of inflammation. This prime may be targeted with drugs to prevent exaggerated neutrophil responses in inflammatory conditions like rheumatoid arthritis.
Researchers have identified CXCR2 as essential for neutrophil migration into the lungs of mice exposed to lipopolysaccharide (LPS). The presence of CXCR2 on blood vessel wall cells and epithelial cells lining airways facilitates this process.
A newly discovered protein called alpha-defensin can kill Bacillus anthracis bacteria, the causative agent of anthrax. The skin form of anthrax is harmless due to neutrophils' ability to identify and kill microbes, whereas the lung form remains fatal, prompting hope for new treatments.
Community-acquired methicillin-resistant S. aureus (MRSA) strains have been found to evade the human immune system, leading to more severe infections in otherwise healthy individuals. The study identified specific genes that may control the bacteria's ability to escape neutrophil destruction.
Researchers found that anthrax's lethal toxin can block neutrophil production of filaments by nearly 60% in just two hours. This paralysis allows the bacteria to move freely in the body, leading to fatal outcomes in inhalation anthrax victims.
Researchers at Michigan Medicine have made significant discoveries on the formation of abdominal aortic aneurysms (AAAs), a leading cause of death worldwide. Two new studies suggest that neutrophils, a type of white blood cell, play a crucial role in AAA formation, particularly in the early stages of the condition.
Researchers found that a yellow-orange pigment produced by Staphylococcus aureus helps the bacteria resist neutrophil killing and produce disease. The discovery provides an novel target for treatment of serious Staph infections, including those caused by antibiotic-resistant MRSA.
Gold-colored bacteria, protected by pigmented carotenoids, evade immune attack and become vulnerable when synthesizers are inhibited. This finding suggests potential new treatments for antibiotic-resistant S. aureus infections.
Researchers at Washington University School of Medicine found that cathepsin G regulates neutrophil secretion of inflammatory chemicals, leading to tissue and cartilage damage in joints. Inhibiting this enzyme has attractive potential as a therapeutic target for treating arthritis.
Researchers found that disabling Foxo3a gene prevents the development of arthritis-like disorder by inducing neutrophil apoptosis. This discovery may lead to new treatment options for immune dysfunction-related arthritic conditions.
Researchers analyzed how neutrophils respond to Anaplasma phagocytophilum, a tick-borne bacterium that causes granulocytic anaplasmosis in humans. The study found that A. phagocytophilum can delay apoptosis in human neutrophils, allowing bacteria to replicate and cause infection.
Researchers found that asthma inflammation directly affects the heart's recovery from a heart attack, increasing cardiac tissue damage. Asthma may be identified as a potential risk factor for post-operative complications and recurrent events following cardiology interventions.
Researchers found that phagocytes reduce IL-23 production after ingesting apoptotic neutrophils, leading to decreased inflammatory response. Abnormal neutrophils with impaired migration resulted in elevated IL-23 and IL-17 levels.
A new type of T lymphocyte called the Tn cell has been discovered by researchers at U.Va. that regulates neutrophil production. The process is known as the neutrophil turnstile, which uses negative feedback to adjust neutrophil numbers in response to bacterial presence.
A Stanford study found that infusing bone marrow cells from a donor mouse into laboratory mice before chemotherapy can significantly improve their ability to fight infections and survive. This new approach boosts neutrophil production, reducing the risk of neutropenia-related complications.
Neutrophils can produce NETs, a net-like structure that binds, disarms, and kills bacteria. This novel defense mechanism was discovered by researchers at the Max Planck Institute for Infection Biology.